Developer docs
API playgroundTry for free, no card

Search company profiles

Martis Capital

Full company profile

uuid0000rpo

Namestring
Martis Capital
Legal namestring
Martis Capital Management, LLC
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Martis Capital is a Washington, DC-headquartered, healthcare-exclusive private equity firm founded in 2011 by Barry Uphoff. The firm invests in middle-market North American healthcare companies with enterprise values of $1-250M+ and equity needs of $25-100M+, targeting founder-led and management-led businesses across four sub-sectors: Healthcare Services & Outsourcing, Healthcare Information Technology, Consumer & Wellness, and Products & Diagnostics. Martis Capital is registered as Martis Capital Management, LLC in Delaware and currently operates from three offices (Washington DC, San Francisco, and Miami) with 11-50 employees.

The firm makes both buyout and growth equity investments, providing portfolio companies with operational support across team building, technology, finance, and M&A. Notable portfolio companies include Centria Healthcare, Altruista Health, Care Hospice, ShareMD, WellHaven PetHealth, Amivie, Archway Dental Partners, Primor Health, Lighthouse Lab Services, Alcanza Clinical Research, MedCap Health, and HHA eXchange. Martis emphasizes a "bespoke" rather than blueprint-driven approach, branding itself as transparent and founder-friendly — a positioning reinforced by five consecutive years on Inc.'s Founder-Friendly Investors list (2021-2025).

Martis Capital generates revenue through traditional private equity economics: recurring management fees on funds under management (currently above $2.2 billion of capital raised across multiple fund vintages since 2011) and carried interest on successful portfolio exits. The firm's fourth fund, Martis Partners IV, LP, closed oversubscribed at $779 million in June 2023, exceeding its $700 million target and marking the largest fund to date. Limited partner commitments come from a global base of institutional investors.

Short descriptiontext

Martis Capital is a healthcare-exclusive private equity firm founded in 2011 that invests in middle-market North American healthcare companies with $1-250M+ enterprise values, managing over $2.2 billion across multiple fund vintages.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, middle-market buyouts, growth equity investments, fund management services, founder-led healthcare
Industry2 codes
PRIMARYFSANABAB
Mid-Market Buyout
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Investment Pools and Funds5259
SIC code1 code
  • Finance Services6199
Product category
Healthcare Private Equity
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees
TypeSubscription Recurring
Description

Martis Capital generates revenue through management fees charged on funds under management, typical for private equity firms. The firm has raised over $2.2 billion across multiple funds since 2011.

martiscapital.com
2Carried Interest / Performance Fees
TypeManaged Services
Description

Private equity returns generated through carried interest from successful portfolio company exits and performance-driven returns on fund investments.

martiscapital.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Martis Capital is a healthcare-exclusive private equity firm that raises and manages investment funds (most recently Martis Partners IV, LP at $779 million) and deploys buyout and growth equity capital into founder-led, middle-market North American healthcare companies with $1-250M+ enterprise values and $25-100M+ equity needs. In addition to capital, the firm provides hands-on value creation support including team building, operational improvements, technology enhancement, and M&A guidance to portfolio companies across four healthcare subsectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Fund IV closed at $779 million, exceeding $700 million target
+2 more records
Product overview1 text field

Martis Capital is a healthcare-focused private equity firm offering investment fund management (Martis Partners IV, LP at $779M) and private equity investment services in middle-market North American healthcare. The firm operates across four healthcare subsectors: Services & Outsourcing, Information Technology, Consumer & Wellness, and Products & Diagnostics. Their portfolio includes diverse companies such as WellHaven PetHealth (veterinary services), Altruista Health (care management software), Alcanza Clinical Research (clinical trials), Amivie (home care), Archway Dental Partners (dental services), Primor Health (primary care), Hospice Care, Centria Healthcare, Care Hospice, MedCap Health (post-acute care), and others.

Product and service2 records
1Martis Partners IV, LP (Fund IV)
CategoryInvestment Fund
Description

Martis Capital's fourth private equity fund with $779 million in capital commitments, targeting middle-market healthcare companies in North America with $1-250M+ enterprise value and $25-100M+ equity needs. Limited-partnership investment vehicle open to institutional and individual investors.

2Healthcare Private Equity Investment Services
CategoryInvestment Service
Description

Buyout and growth equity investment services paired with bespoke strategic, operational, technology, and M&A support for founder-led middle-market healthcare companies across four subsectors. Delivered through multiple fund vintages to founders and management teams seeking growth capital and operational partnership.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Welsh Carson is a long-tenured, healthcare-focused private equity firm investing across services, information technology, and growth equity, making it the closest pure-play healthcare PE peer to Martis Capital.

TypeDirect peer
Description

Linden Capital is a healthcare-focused middle-market PE firm making buyout and growth investments across healthcare services and products, directly comparable in sector focus and deal size to Martis.

TypeDirect peer
Description

Avista Capital is a healthcare-focused middle-market private equity firm investing in pharma services, medical products, and healthcare services, closely matching Martis's healthcare-only strategy.

TypeDirect peer
Description

Ampersand Capital is a middle-market PE firm specializing in healthcare and life sciences, including pharma services, diagnostics, and healthcare IT, directly comparable to Martis's healthcare and healthcare-IT verticals.

TypeBroad incumbent
Description

New Mountain is a large-cap growth-oriented investment firm with a significant healthcare services and healthcare IT franchise, competing with Martis for larger founder-led healthcare assets.

TypeBroad incumbent
Description

Bain Capital runs a global PE franchise with a dedicated healthcare vertical across services, life sciences, and technology, competing with Martis at the upper end of the middle market.

TypeBroad incumbent
Description

TPG operates a large global PE platform with dedicated healthcare buyout and growth strategies, serving as a broader incumbent competing for healthcare deals that exceed Martis's typical equity check size.

TypeEmerging player
Description

Incline Equity is a middle-market PE firm with a value creation orientation, comparable in size and operating approach to Martis (and a recent employer of Martis principal Beth Dresdale).

TypeEmerging player
Description

Audax is a middle-market PE firm executing buy-and-build strategies across healthcare and business services, comparable in fund size and middle-market focus to Martis.

TypeEmerging player
Description

Quad-C is a middle-market PE firm with a healthcare services focus (a prior employer of Martis Partner Chris Beall), making it a directly comparable middle-market peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment22 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Martis Capital

Healthcare Private Equitymartiscapital.com

Martis Capital is a healthcare-exclusive private equity firm founded in 2011 that invests in middle-market North American healthcare companies with $1-250M+ enterprise values, managing over $2.2 billion across multiple fund vintages.

What Martis Capital does

Martis Capital is a Washington, DC-headquartered, healthcare-exclusive private equity firm founded in 2011 by Barry Uphoff. The firm invests in middle-market North American healthcare companies with enterprise values of $1-250M+ and equity needs of $25-100M+, targeting founder-led and management-led businesses across four sub-sectors: Healthcare Services & Outsourcing, Healthcare Information Technology, Consumer & Wellness, and Products & Diagnostics. Martis Capital is registered as Martis Capital Management, LLC in Delaware and currently operates from three offices (Washington DC, San Francisco, and Miami) with 11-50 employees.

The firm makes both buyout and growth equity investments, providing portfolio companies with operational support across team building, technology, finance, and M&A. Notable portfolio companies include Centria Healthcare, Altruista Health, Care Hospice, ShareMD, WellHaven PetHealth, Amivie, Archway Dental Partners, Primor Health, Lighthouse Lab Services, Alcanza Clinical Research, MedCap Health, and HHA eXchange. Martis emphasizes a "bespoke" rather than blueprint-driven approach, branding itself as transparent and founder-friendly — a positioning reinforced by five consecutive years on Inc.'s Founder-Friendly Investors list (2021-2025).

Martis Capital generates revenue through traditional private equity economics: recurring management fees on funds under management (currently above $2.2 billion of capital raised across multiple fund vintages since 2011) and carried interest on successful portfolio exits. The firm's fourth fund, Martis Partners IV, LP, closed oversubscribed at $779 million in June 2023, exceeding its $700 million target and marking the largest fund to date. Limited partner commitments come from a global base of institutional investors.

Martis Capital firmographics

Firmographics
Name
Martis Capital
Legal name
Martis Capital Management, LLC
Website
https://martiscapital.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Martis Capital is a healthcare-exclusive private equity firm founded in 2011 that invests in middle-market North American healthcare companies with $1-250M+ enterprise values, managing over $2.2 billion across multiple fund vintages.
Ownership category
akta.pro rank

Martis Capital industry classification

Industry
Product category
Healthcare Private Equity
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Other Investment Pools and Funds (5259)
SIC
Finance Services (6199)
akta.pro industry
PRIMARYFSANABAB
Mid-Market Buyout
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity

Keywords

  • Healthcare private equity
  • Middle-market buyouts
  • Growth equity investments
  • Fund management services
  • Founder-led healthcare

Where Martis Capital is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Martis Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fund Management Fees: Martis Capital generates revenue through management fees charged on funds under management, typical for private equity firms. The firm has raised over $2.2 billion across multiple funds since 2011.
  2. Carried Interest / Performance Fees: Private equity returns generated through carried interest from successful portfolio company exits and performance-driven returns on fund investments.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Martis Capital product offering

Product offering

Core offering

Martis Capital is a healthcare-exclusive private equity firm that raises and manages investment funds (most recently Martis Partners IV, LP at $779 million) and deploys buyout and growth equity capital into founder-led, middle-market North American healthcare companies with $1-250M+ enterprise values and $25-100M+ equity needs. In addition to capital, the firm provides hands-on value creation support including team building, operational improvements, technology enhancement, and M&A guidance to portfolio companies across four healthcare subsectors.

Product overview

Martis Capital is a healthcare-focused private equity firm offering investment fund management (Martis Partners IV, LP at $779M) and private equity investment services in middle-market North American healthcare. The firm operates across four healthcare subsectors: Services & Outsourcing, Information Technology, Consumer & Wellness, and Products & Diagnostics. Their portfolio includes diverse companies such as WellHaven PetHealth (veterinary services), Altruista Health (care management software), Alcanza Clinical Research (clinical trials), Amivie (home care), Archway Dental Partners (dental services), Primor Health (primary care), Hospice Care, Centria Healthcare, Care Hospice, MedCap Health (post-acute care), and others.

Differentiator

Problem solved

Functional benefit

Products and services

  • Martis Partners IV, LP (Fund IV) Martis Capital's fourth private equity fund with $779 million in capital commitments, targeting middle-market healthcare companies in North America with $1-250M+ enterprise value and $25-100M+ equity needs. Limited-partnership investment vehicle open to institutional and individual investors.
  • Healthcare Private Equity Investment Services Buyout and growth equity investment services paired with bespoke strategic, operational, technology, and M&A support for founder-led middle-market healthcare companies across four subsectors. Delivered through multiple fund vintages to founders and management teams seeking growth capital and operational partnership.

Quantifiable outcome

  • Fund IV closed at $779 million, exceeding $700 million target
  • +2 more outcomes

Companies that use Martis Capital

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Martis Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Martis Capital partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Martis Capital competitors and assessment

Company assessment

Direct peers

  • Welsh, Carson, Anderson & Stowe: Welsh Carson is a long-tenured, healthcare-focused private equity firm investing across services, information technology, and growth equity, making it the closest pure-play healthcare PE peer to Martis Capital.
  • Linden Capital Partners: Linden Capital is a healthcare-focused middle-market PE firm making buyout and growth investments across healthcare services and products, directly comparable in sector focus and deal size to Martis.
  • Avista Capital Partners: Avista Capital is a healthcare-focused middle-market private equity firm investing in pharma services, medical products, and healthcare services, closely matching Martis's healthcare-only strategy.
  • Ampersand Capital Partners: Ampersand Capital is a middle-market PE firm specializing in healthcare and life sciences, including pharma services, diagnostics, and healthcare IT, directly comparable to Martis's healthcare and healthcare-IT verticals.

Broad incumbents

  • New Mountain Capital: New Mountain is a large-cap growth-oriented investment firm with a significant healthcare services and healthcare IT franchise, competing with Martis for larger founder-led healthcare assets.
  • Bain Capital Private Equity: Bain Capital runs a global PE franchise with a dedicated healthcare vertical across services, life sciences, and technology, competing with Martis at the upper end of the middle market.
  • TPG Capital: TPG operates a large global PE platform with dedicated healthcare buyout and growth strategies, serving as a broader incumbent competing for healthcare deals that exceed Martis's typical equity check size.

Emerging players

  • Incline Equity Partners: Incline Equity is a middle-market PE firm with a value creation orientation, comparable in size and operating approach to Martis (and a recent employer of Martis principal Beth Dresdale).
  • Audax Group: Audax is a middle-market PE firm executing buy-and-build strategies across healthcare and business services, comparable in fund size and middle-market focus to Martis.
  • Quad-C Management: Quad-C is a middle-market PE firm with a healthcare services focus (a prior employer of Martis Partner Chris Beall), making it a directly comparable middle-market peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Martis Capital social profiles

Digital presence

Martis Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Martis Capital leadership team

Management profile

Number of profiles

Profiles19 records

Martis Capital funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Martis Capital M&A and investment

M&A and investment

M&A2 records

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Martis Capital

What does Martis Capital do?

Martis Capital is a healthcare-exclusive private equity firm that raises and manages investment funds (most recently Martis Partners IV, LP at $779 million) and deploys buyout and growth equity capital into founder-led, middle-market North American healthcare companies with $1-250M+ enterprise values and $25-100M+ equity needs. In addition to capital, the firm provides hands-on value creation support including team building, operational improvements, technology enhancement, and M&A guidance to portfolio companies across four healthcare subsectors.

Is Martis Capital a public or private company?

Martis Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Martis Capital founded?

Martis Capital was founded in 2011. It employs 11 to 50 people.

Where is Martis Capital based?

Martis Capital is headquartered in San Francisco, United States, in the North America region.

How does Martis Capital make money?

Two revenue lines are on record. Fund Management Fees are the primary driver. The others are carried Interest / Performance Fees.

Who are Martis Capital's main competitors?

Direct peers on record are Welsh, Carson, Anderson & Stowe, Linden Capital Partners, Avista Capital Partners and Ampersand Capital Partners. Broad incumbents are New Mountain Capital, Bain Capital Private Equity and TPG Capital. Emerging players are Incline Equity Partners, Audax Group and Quad-C Management.

Does Martis Capital have an API?

No public API is recorded for Martis Capital.

What industry is Martis Capital in?

Martis Capital's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANABAB, Mid-Market Buyout, with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 525 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMartis Capital Named to Inc.'s 2026 Founder-Friendly Investors List for Sixth Consecutive YearMartis Capital was named to Inc.'s 2026 Founder-Friendly Investors list for the sixth consecutive year, joining 14 healthcare-exclusive private equity firms. The firm has raised over $2.2 billion since 2011 to invest in middle-market healthcare companies.FiercePharmaDeerfield goes on hiring, promotion spree for ‘Built for This’ growth phaseDeerfield Group is appointing Brian Rocks as CFO and Shelby Rauen as head of strategy, plus expanding roles for other executives, to support its 'Built for This' growth model. The agency, backed by Martis Capital, will launch an Industry Pain Benchmark Survey at Fierce Pharma Week to gather client insights.PR NewswireMartis Capital, Healthcare-Focused PE Firm, Names Lindsey Zolet and Anthony Tsai to Executive RolesMartis Capital Management named Lindsey Zolet chief financial officer and Anthony Tsai chief compliance officer and director of finance. Zolet joined in 2021 as controller, Tsai in 2019 as controller. The firm has $2.4 billion in assets under management.BitlyScoop: Martis Capital selling Alcanza Clinical ResearchMartis Capital is working with Jefferies to sell Alcanza Clinical Research. This transaction highlights the continued interest of private equity in clinical trial site networks, which are currently viewed favorably due to fewer reimbursement challenges compared to other multi-site healthcare providers.Pulse 2.0Martis Capital Acquires Majority Stake In Deerfield GroupMartis Capital, a private equity firm focused on the middle-market healthcare industry, has acquired a majority equity stake in Deerfield Group, a marketing, communications, media, and technology agency serving healthcare and life sciences companies. Financial terms of the transaction were not disclosed, though Deerfield Group's founders and management team will retain significant ownership in the company. The investment is intended to provide Deerfield Group with additional resources to expand capabilities, strengthen current offerings, and develop new technology solutions, including analytics and AI-enabled services.VenturecapitalMartis Capital Acquires Majority Stake in Healthcare Marketing and Media FirmMartis Capital Management completed the acquisition of a majority equity stake in Deerfield Group, a healthcare and life sciences marketing and media firm. The deal aims to accelerate Deerfield Group's expansion and enhance its capabilities for biotech and pharma clients.Third NewsMartis Capital Expands Influence by Acquiring Majority Stake in Deerfield GroupMartis Capital Management, a private equity firm focused on healthcare investments, has acquired a majority stake in Deerfield Group, a healthcare marketing, communications, and media agency. Deerfield Group has achieved over 30% revenue growth since 2017 and will maintain its founders and leadership team while gaining access to Martis Capital's resources and platform development capabilities. The partnership aims to enhance Deerfield's AI capabilities and analytical tools to deliver more strategic marketing solutions for biotechnology and pharmaceutical clients.PR NewswireMartis Capital, Healthcare-Focused PE Firm, Acquires Majority Stake in Healthcare Marketing, Communications, and Media Agency Deerfield GroupMartis Capital Management, a private equity firm focused on the middle market healthcare industry, has acquired a majority equity stake in Deerfield Group, a marketing, communications, and media agency serving the healthcare and life sciences sectors. Deerfield Group, based in the Philadelphia area, has grown revenue by more than 30 percent annually since 2017 and will use the investment to expand capabilities and develop new technology solutions. The founders and Deerfield Group management team retain significant ownership interest in the company.PR NewswireDEERFIELD GROUP ANNOUNCES STRATEGIC INVESTMENT FROM MARTIS CAPITAL TO FUEL NEXT PHASE OF GROWTHDeerfield Group, a healthcare marketing and communications agency, announced receiving a strategic majority investment from Martis Capital, a private equity firm focused exclusively on the healthcare sector, marking the transition from its successful investment period with Edgewater Funds during which Deerfield achieved more than 30 percent year-over-year growth since 2017. The investment will accelerate development of Deerfield's proprietary solutions including AI-enabled tools and the recently launched Prismatiq™ field enablement platform, while Alexandra von Plato, former CEO of Publicis Health, joins the board of directors. Deerfield has risen from #52 to #39 in the MM&M Top 100 Agency rankings from 2024 to 2026.Venture Capital Access OnlineMartis Capital, Healthcare-Focused PE Firm, Acquires Majority Stake in Healthcare Marketing, Communications, and Media Agency Deerfield GroupMartis Capital acquired a majority stake in Deerfield Group, a healthcare marketing and media agency, with founders retaining significant ownership. Deerfield has grown revenue by over 30% annually since 2017. The investment aims to expand capabilities and develop new technology solutions for healthcare clients.